tiprankstipranks
Trending News
More News >
Phathom Pharmaceuticals (PHAT)
NASDAQ:PHAT
US Market

Phathom Pharmaceuticals (PHAT) Technical Analysis

Compare
588 Followers

Technical Sentiment

Overall Consensus
Sell
8Bullish
2Neutral
12Bearish
Technical Analysis Consensus
Buy
6Bullish
2Neutral
2Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
Phathom Pharmaceuticals’s (PHAT) Moving Averages Convergence Divergence (MACD) indicator is -0.68, suggesting Phathom Pharmaceuticals is a Buy.
Phathom Pharmaceuticals’s (PHAT) 20-Day exponential moving average is 13.87, while Phathom Pharmaceuticals’s (PHAT) share price is $12.78, making it a Sell.
Phathom Pharmaceuticals’s (PHAT) 50-Day exponential moving average is 14.38, while Phathom Pharmaceuticals’s (PHAT) share price is $12.78, making it a Sell.

Phathom Pharmaceuticals (PHAT) Pivot Points

Feb 12, 2026, 11:02 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
11.47
11.83
12.21
12.57
12.95
13.31
13.69
Fibonacci
11.83
12.12
12.29
12.57
12.86
13.03
13.31
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Phathom Pharmaceuticals (PHAT) Moving Averages

Feb 12, 2026, 11:02 AM
Period
Simple
Exponential
MA5
12.96Sell
12.93Sell
MA10
13.39Sell
13.29Sell
MA20
13.88Sell
13.87Sell
MA50
15.03Sell
14.38Sell
MA100
14.04Sell
13.66Sell
MA200
11.10Buy
11.12Buy
Phathom Pharmaceuticals’s (PHAT) 10-Day exponential moving average is 13.29, while Phathom Pharmaceuticals’s (PHAT) share price is $12.78, making it a Sell.
Phathom Pharmaceuticals’s (PHAT) 100-Day exponential moving average is 13.66, while Phathom Pharmaceuticals’s (PHAT) share price is $12.78, making it a Sell.
Phathom Pharmaceuticals’s (PHAT) stock price is $12.78 and Phathom Pharmaceuticals’s (PHAT) 50-day simple moving average is 15.03, creating a Sell signal.
Phathom Pharmaceuticals’s (PHAT) stock price is $12.78 and Phathom Pharmaceuticals’s (PHAT) 100-day simple moving average is 14.04, creating a Sell signal.
Phathom Pharmaceuticals’s (PHAT) stock price is $12.78 and Phathom Pharmaceuticals’s (PHAT) 200-day simple moving average is 11.10, creating a Buy signal.

Phathom Pharmaceuticals (PHAT) Technical Indicators

Feb 12, 2026, 11:02 AM
Name
Value
Implied Action
RSI (14)
38.22
Neutral
STOCH (9,6)
16.48
Buy
STOCHRSI (14)
15.24
Buy
MACD (12,26)
-0.68
Buy
ADX (14)
17.51
Buy
Williams %R
-76.57
Buy
CCI (14)
-139.23
Buy
ATR (14)
0.94
-
Ultimate Oscillator
39.68
Neutral
ROC
-9.68
Sell
Phathom Pharmaceuticals’s (PHAT) Relative Strength Index (RSI) is 38.22, creating a Neutral signal.
Phathom Pharmaceuticals’s (PHAT) Trend Strength Indicator (ADX) is 17.51, creating a Buy signal.
Phathom Pharmaceuticals’s (PHAT) Commodity Channel Index (CCI) is -139.23, creating a Buy signal.
Phathom Pharmaceuticals’s (PHAT) Price Rate of Change (ROC) is -9.68, creating a Sell signal.

FAQ

Is PHAT a Buy, Hold, or Sell?
Based on PHAT’s technical indicators, PHAT is a Sell.
    What is PHAT’s RSI (14)?
    PHAT’s RSI (14) is 38.22, which suggests PHAT is a Neutral.
      What is PHAT’s MACD?
      PHAT’s MACD is -0.68, which suggests PHAT is a Buy.
        What is PHAT’s 5-day moving average?
        PHAT’s 5-day moving average is 12.96, which suggests PHAT is a Sell.
          What is PHAT’s 20-day moving average?
          PHAT 20-day moving average is 13.88, which suggests PHAT is a Sell.
            What is PHAT’s 50-day moving average?
            PHAT’s 50-day moving average is 15.03, which suggests PHAT is a Sell.
              What is PHAT’s 200-day moving average?
              PHAT’s 200-day moving average is 11.10, which suggests PHAT is a Buy.
                What is PHAT’s Williams % R (14)?
                PHAT’s Williams % R (14) is -76.57, which suggests PHAT is a Buy.
                  What is PHAT’s CCI (14)?
                  PHAT’s CCI (14) is -139.23, which suggests PHAT is a Buy.